Swedish Orphan Biovitrum AB (GB:0MTD)
LSE:0MTD
Holding GB:0MTD?
Track your performance easily

Swedish Orphan Biovitrum AB (0MTD) Income Statement

1 Followers

Swedish Orphan Biovitrum AB Income Statement

Last quarter (Q4 2022), Swedish Orphan Biovitrum AB's total revenue was kr5.99B, an increase of 22.34% from the same quarter last year. In Q4, Swedish Orphan Biovitrum AB's net income was kr1.39B. See Swedish Orphan Biovitrum AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
kr 18.79Bkr 18.79Bkr 15.53Bkr 15.26Bkr 14.25Bkr 9.14B
Cost of Revenue
kr 4.78Bkr 4.78Bkr 3.48Bkr 3.23Bkr 3.33Bkr 2.42B
Gross Profit
kr 14.01Bkr 14.01Bkr 12.04Bkr 12.04Bkr 10.91Bkr 6.72B
Operating Expense
kr 10.17Bkr 10.17Bkr 8.26Bkr 7.57Bkr 6.41Bkr 3.60B
Operating Income
kr 3.85Bkr 3.85Bkr 3.79Bkr 4.46Bkr 4.50Bkr 3.13B
Net Non Operating Interest Income Expense
kr -481.00Mkr -481.00Mkr -454.00Mkr -486.00Mkr -255.00Mkr -56.00M
Other Income Expense
------
Pretax Income
kr 3.32Bkr 3.32Bkr 3.29Bkr 4.22Bkr 4.25Bkr 3.08B
Tax Provision
kr 684.00Mkr 683.00Mkr 616.00Mkr 972.00Mkr 942.00Mkr 664.00M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr 2.64Bkr 2.64Bkr 2.68Bkr 3.25Bkr 3.30Bkr 2.42B
Basic EPS
kr 7.07kr 8.92kr 9.08kr 11.01kr 11.29kr 8.97
Diluted EPS
kr 7.02kr 8.84kr 9.03kr 10.90kr 11.22kr 8.93
Basic Average Shares
kr 1.18Bkr 295.60Mkr 295.05Mkr 294.66Mkr 292.65Mkr 269.52M
Diluted Average Shares
kr 1.19Bkr 298.45Mkr 296.80Mkr 297.64Mkr 294.53Mkr 270.60M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
kr 9.88kr 10.77kr 9.08kr 9.66kr 11.89kr 8.97
Reported Normalized Diluted E P S
kr 9.79kr 10.66kr 9.03kr 9.56kr 11.81kr 8.93
Rent Expense Supplemental
----kr 7.00Mkr 87.00M
Total Expenses
kr 14.95Bkr 14.95Bkr 11.74Bkr 10.80Bkr 9.74Bkr 6.01B
Net Income From Continuing And Discontinued Operation
kr 2.64Bkr 2.64Bkr 2.68Bkr 3.25Bkr 3.30Bkr 2.42B
Normalized Income
kr 2.64Bkr 2.64Bkr 2.72Bkr 2.94Bkr 3.28Bkr 2.42B
Interest Expense
kr 6.00Mkr 458.00Mkr 419.00Mkr 454.00Mkr 241.00Mkr 56.00M
EBIT
kr 3.68Bkr 3.78Bkr 3.71Bkr 4.67Bkr 4.49Bkr 3.14B
EBITDA
kr 6.10Bkr 6.20Bkr 5.72Bkr 6.69Bkr 6.08Bkr 3.62B
Currency in SEK

Swedish Orphan Biovitrum AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis